Celldex Therapeutics, Inc. Proceeds from Sale and Maturity of Marketable Securities
Celldex Therapeutics, Inc. (CLDX) reported Proceeds from Sale and Maturity of Marketable Securities of $283.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-08-06
- Celldex Therapeutics, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2026-06-30 was $150.51M, a 12.92% decline year-over-year.
- Celldex Therapeutics, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2026-03-31 was $133.37M, a 31.62% decline year-over-year.
- Celldex Therapeutics, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2025-12-31 was $111.50M, a 27.59% decline year-over-year.
- Celldex Therapeutics, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2025-09-30 was $116.92M, a 21.20% decline year-over-year.
- Celldex Therapeutics, Inc. proceeds from sale and maturity of marketable securities for fiscal 2025 was $596.29M, a 18.85% increase from fiscal 2024.
- Celldex Therapeutics, Inc. proceeds from sale and maturity of marketable securities for fiscal 2024 was $501.71M, a 56.49% increase from fiscal 2023.
- Celldex Therapeutics, Inc. proceeds from sale and maturity of marketable securities for fiscal 2023 was $320.60M, a 14.23% increase from fiscal 2022.
- Celldex Therapeutics, Inc. proceeds from sale and maturity of marketable securities for fiscal 2022 was $280.67M, a 60.43% increase from fiscal 2021.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $150.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $283.88M 10-Q · filed 2026-08-06 | $395.38M derived: sum of 3 quarters · filed 2026-08-06 | $512.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $133.37M 10-Q · filed 2026-05-07 | $244.87M derived: sum of 2 quarters · filed 2026-05-07 | $361.78M derived: sum of 3 quarters · filed 2026-05-07 | $534.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $111.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $228.41M derived: sum of 2 quarters · filed 2026-02-25 | $401.25M derived: sum of 3 quarters · filed 2026-08-06 | $596.29M 10-K · filed 2026-02-25 |
| 2025-09-30 | $116.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $289.75M derived: sum of 2 quarters · filed 2026-08-06 | $484.79M 10-Q · filed 2025-11-10 | $638.77M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $172.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $367.87M 10-Q · filed 2026-08-06 | $521.86M derived: sum of 3 quarters · filed 2026-08-06 | $670.22M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $195.04M 10-Q · filed 2026-05-07 | $349.02M derived: sum of 2 quarters · filed 2026-05-07 | $497.38M derived: sum of 3 quarters · filed 2026-05-07 | $619.44M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $153.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $302.34M derived: sum of 2 quarters · filed 2026-02-25 | $424.40M derived: sum of 3 quarters · filed 2026-02-25 | $501.71M 10-K · filed 2026-02-25 |
| 2024-09-30 | $148.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $270.42M derived: sum of 2 quarters · filed 2025-11-10 | $347.73M 10-Q · filed 2025-11-10 | $418.63M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $122.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $199.37M 10-Q · filed 2025-08-07 | $270.26M derived: sum of 3 quarters · filed 2026-02-25 | $309.82M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $77.31M 10-Q · filed 2025-05-08 | $148.21M derived: sum of 2 quarters · filed 2026-02-25 | $187.76M derived: sum of 3 quarters · filed 2026-02-25 | $270.91M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $70.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $110.45M derived: sum of 2 quarters · filed 2026-02-25 | $193.60M derived: sum of 3 quarters · filed 2026-02-25 | $320.60M 10-K · filed 2026-02-25 |
| 2023-09-30 | $39.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $122.70M derived: sum of 2 quarters · filed 2024-11-06 | $249.70M 10-Q · filed 2024-11-06 | $337.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $83.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $210.15M 10-Q · filed 2024-08-08 | $297.95M derived: sum of 3 quarters · filed 2025-02-27 | $384.06M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $127.00M 10-Q · filed 2024-05-06 | $214.80M derived: sum of 2 quarters · filed 2025-02-27 | $300.91M derived: sum of 3 quarters · filed 2025-02-27 | $379.82M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $87.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $173.91M derived: sum of 2 quarters · filed 2025-02-27 | $252.82M derived: sum of 3 quarters · filed 2025-02-27 | $280.67M 10-K · filed 2025-02-27 |
| 2022-09-30 | $86.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $165.02M derived: sum of 2 quarters · filed 2023-11-02 | $192.87M 10-Q · filed 2023-11-02 | $238.81M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $78.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $106.76M 10-Q · filed 2023-08-08 | $152.70M derived: sum of 3 quarters · filed 2024-02-26 | $165.70M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $27.84M 10-Q · filed 2023-05-04 | $73.79M derived: sum of 2 quarters · filed 2024-02-26 | $86.79M derived: sum of 3 quarters · filed 2024-02-26 | $124.79M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $45.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $58.95M derived: sum of 2 quarters · filed 2024-02-26 | $96.95M derived: sum of 3 quarters · filed 2024-02-26 | $174.95M 10-K · filed 2024-02-26 |
| 2021-09-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $51.00M derived: sum of 2 quarters · filed 2022-11-09 | $129.00M 10-Q · filed 2022-11-09 | $197.00M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $38.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $116.00M 10-Q · filed 2022-08-08 | $184.00M derived: sum of 3 quarters · filed 2023-02-28 | $192.60M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $78.00M 10-Q · filed 2022-05-05 | $146.00M derived: sum of 2 quarters · filed 2023-02-28 | $154.60M derived: sum of 3 quarters · filed 2023-02-28 | $179.40M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $76.60M derived: sum of 2 quarters · filed 2023-02-28 | $101.40M derived: sum of 3 quarters · filed 2023-02-28 | $123.60M 10-K · filed 2023-02-28 |
| 2020-09-30 | $8.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $33.40M derived: sum of 2 quarters · filed 2021-11-09 | $55.60M 10-Q · filed 2021-11-09 | $77.30M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $24.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $47.00M 10-Q · filed 2021-08-05 | $68.70M derived: sum of 3 quarters · filed 2022-02-28 | $92.79M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $22.20M 10-Q · filed 2021-05-06 | $43.90M derived: sum of 2 quarters · filed 2022-02-28 | $67.99M derived: sum of 3 quarters · filed 2022-02-28 | $97.49M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $21.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $45.79M derived: sum of 2 quarters · filed 2022-02-28 | $75.29M derived: sum of 3 quarters · filed 2022-02-28 | $113.17M 10-K · filed 2022-02-28 |
| 2019-09-30 | $24.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $53.59M derived: sum of 2 quarters · filed 2020-11-05 | $91.47M 10-Q · filed 2020-11-05 | $114.61M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-06-30 | $29.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $67.39M 10-Q · filed 2020-08-06 | $90.52M derived: sum of 3 quarters · filed 2021-03-29 | $162.67M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-03-31 | $37.89M 10-Q · filed 2020-05-06 | $61.02M derived: sum of 2 quarters · filed 2021-03-29 | $133.17M derived: sum of 3 quarters · filed 2021-03-29 | $192.48M derived: sum of 4 quarters · filed 2021-03-29 |
| 2018-12-31 | $23.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $95.29M derived: sum of 2 quarters · filed 2021-03-29 | $154.60M derived: sum of 3 quarters · filed 2021-03-29 | $201.47M 10-K · filed 2021-03-29 |
| 2018-09-30 | $72.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $131.46M derived: sum of 2 quarters · filed 2019-11-12 | $178.34M 10-Q · filed 2019-11-12 | $213.89M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-06-30 | $59.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $106.18M 10-Q · filed 2019-08-07 | $141.74M derived: sum of 3 quarters · filed 2020-03-26 | $173.95M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-03-31 | $46.87M 10-Q · filed 2019-05-07 | $82.42M derived: sum of 2 quarters · filed 2020-03-26 | $114.64M derived: sum of 3 quarters · filed 2020-03-26 | $192.37M derived: sum of 4 quarters · filed 2020-03-26 |
| 2017-12-31 | $35.55M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $67.77M derived: sum of 2 quarters · filed 2020-03-26 | $145.50M derived: sum of 3 quarters · filed 2020-03-26 | $219.24M 10-K · filed 2020-03-26 |
| 2017-09-30 | $32.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $109.95M derived: sum of 2 quarters · filed 2018-11-07 | $183.68M 10-Q · filed 2018-11-07 | $231.56M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $77.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $151.47M 10-Q · filed 2018-08-08 | $199.35M derived: sum of 3 quarters · filed 2019-03-07 | $244.90M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $73.74M 10-Q · filed 2018-05-10 | $121.61M derived: sum of 2 quarters · filed 2019-03-07 | $167.16M derived: sum of 3 quarters · filed 2019-03-07 | $241.59M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $47.88M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $93.42M derived: sum of 2 quarters · filed 2019-03-07 | $167.85M derived: sum of 3 quarters · filed 2019-03-07 | $242.79M 10-K · filed 2019-03-07 |
| 2016-09-30 | $45.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $119.98M derived: sum of 2 quarters · filed 2017-11-07 | $194.91M 10-Q · filed 2017-11-07 | $226.66M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | $74.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $149.37M 10-Q · filed 2017-08-08 | $181.11M derived: sum of 3 quarters · filed 2018-03-07 | $224.11M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | $74.94M 10-Q · filed 2017-05-09 | $106.68M derived: sum of 2 quarters · filed 2018-03-07 | $149.68M derived: sum of 3 quarters · filed 2018-03-07 | $178.96M derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | $31.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $74.75M derived: sum of 2 quarters · filed 2018-03-07 | $104.02M derived: sum of 3 quarters · filed 2018-03-07 | $161.09M 10-K · filed 2018-03-07 |
| 2015-09-30 | $43.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $72.28M derived: sum of 2 quarters · filed 2016-11-07 | $129.35M 10-Q · filed 2016-11-07 | $149.37M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $29.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $86.34M 10-Q · filed 2016-08-08 | $106.36M derived: sum of 3 quarters · filed 2017-03-14 | $144.99M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $57.07M 10-Q · filed 2016-05-05 | $77.08M derived: sum of 2 quarters · filed 2017-03-14 | $115.71M derived: sum of 3 quarters · filed 2017-03-14 | $135.02M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $20.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $58.65M derived: sum of 2 quarters · filed 2017-03-14 | $77.95M derived: sum of 3 quarters · filed 2017-03-14 | $109.23M 10-K · filed 2017-03-14 |
| 2014-09-30 | $38.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $57.93M derived: sum of 2 quarters · filed 2015-11-05 | $89.22M 10-Q · filed 2015-11-05 | $97.43M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $19.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $50.59M 10-Q · filed 2015-08-10 | $58.80M derived: sum of 3 quarters · filed 2016-02-25 | $68.90M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $31.28M 10-Q · filed 2015-04-29 | $39.50M derived: sum of 2 quarters · filed 2016-02-25 | $49.59M derived: sum of 3 quarters · filed 2016-02-25 | $62.78M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $8.21M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | $18.31M derived: sum of 2 quarters · filed 2016-02-25 | $31.50M derived: sum of 3 quarters · filed 2016-02-25 | $38.89M 10-K/A · filed 2016-02-25 |
| 2013-09-30 | $10.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $23.29M derived: sum of 2 quarters · filed 2014-11-05 | $30.68M 10-Q · filed 2014-11-05 | $37.61M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $13.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $20.58M 10-Q · filed 2014-08-07 | $27.51M derived: sum of 3 quarters · filed 2015-02-24 | $52.02M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $7.39M 10-Q · filed 2014-05-01 | $14.32M derived: sum of 2 quarters · filed 2015-02-24 | $38.84M derived: sum of 3 quarters · filed 2015-02-24 | $53.84M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $6.93M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $31.44M derived: sum of 2 quarters · filed 2015-02-24 | $46.45M derived: sum of 3 quarters · filed 2015-02-24 | $52.36M 10-K · filed 2015-02-24 |
| 2012-09-30 | $24.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $39.52M derived: sum of 2 quarters · filed 2013-11-08 | $45.43M 10-Q · filed 2013-11-08 | $58.08M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $15.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $20.92M 10-Q · filed 2013-08-06 | $33.57M derived: sum of 3 quarters · filed 2014-03-03 | $53.53M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $5.91M 10-Q · filed 2013-05-03 | $18.56M derived: sum of 2 quarters · filed 2014-03-03 | $38.52M derived: sum of 3 quarters · filed 2014-03-03 | $48.26M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $12.65M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $32.61M derived: sum of 2 quarters · filed 2014-03-03 | $42.35M derived: sum of 3 quarters · filed 2014-03-03 | $51.00M 10-K · filed 2014-03-03 |
| 2011-09-30 | $19.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $29.70M derived: sum of 2 quarters · filed 2012-11-02 | $38.35M 10-Q · filed 2012-11-02 | $50.53M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-06-30 | $9.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $18.39M 10-Q · filed 2012-08-09 | $30.57M derived: sum of 3 quarters · filed 2013-03-08 | $41.52M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-03-31 | $8.65M 10-Q · filed 2012-05-04 | $20.83M derived: sum of 2 quarters · filed 2013-03-08 | $31.78M derived: sum of 3 quarters · filed 2013-03-08 | |
| 2010-12-31 | $12.17M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $23.13M derived: sum of 2 quarters · filed 2013-03-08 | $42.38M 10-K · filed 2013-03-08 | |
| 2010-09-30 | $10.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $30.21M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $19.25M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $2.67M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |